The PROPEL family of sinus implants reduced the need for post-operative intervention vs a non-drug implant. For example, PROPEL Contour reduced the need for postoperative interventions by 65% vs surgery alone, at 30 days following frontal sinus surgery.1
If you’re planning to have sinus surgery to treat your chronic sinusitis, you may not get the relief you’d hoped for. Nearly 1 in 6 patients will need additional surgery. Fortunately, the innovative technology of the PROPEL family of stents is here to provide help.
Please see important safety information at the bottom of the page.
25% of patients report depression
Because symptoms so closely resemble those of seasonal allergies or a cold you may misdiagnose yourself and neglect to seek treatment.
Chronic sinusitis impacts much more than your physical well-being. Around 25% of patients report depression, as well as increased body pain and impaired social functioning, compared with patients who have other chronic health conditions. Your quality of life may suffer – which is why speaking to an ENT specialist about your treatment options is so important.
PROPEL is a bioabsorbable stent placed following sinus surgery to keep the sinus open using a spring-like mechanism. The stent delivers steroid medication to the sinus tissue for up to 30 days. Over time, it dissolves on its own, so removal isn’t required, but the doctor can remove it at any time. PROPEL has been proven to reduce inflammation/edema and the need for oral steroids. In clinical studies, patients using PROPEL needed less post-surgery intervention at 30 days compared with patients not using PROPEL.2
Intersect ENT makes information available about physicians who can provide the PROPEL Sinus Stent. Physicians are listed based on the proximity to the zip code that you entered. Intersect ENT does not have any vested interest in any specific physicians, nor do we provide any recommendation, assurance, or guarantee with respect to their service. Intersect ENT does not endorse, recommend, certify, or make any expressed or implied warranty with respect to the credentials, qualifications, or abilities of any of these physicians.
Luong A, Ow RA, Singh A et al. JAMA Otolaryngol Head Neck Surg. 144(1): 28-35, 2018. Judged at Day 30 by Independent Reviewer. The ITT population of N=80.
Han JK et al. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis. Int Forum Allergy Rhinol. 2012;2(4): 271-279. https://pubmed.ncbi.nlm.nih.gov/22550039/